Swedish study by Lindstrom U et al of over 3000 PsA patients matched with RA comparators showed that the length of time on MTX (PsA 4.5 and RA 4.4 years) before adding or switching to b/tsDMARD was identical in PsA (34%) and matched RA controls (33%) #EULAR2022 @RheumNow POS0073 https://t.co/Dwrz8RVMnh

#EULAR2022 OP0276: What do patients want for preventative interventions for RA? ⭐️Survey of 1st degree relatives of RA pts (at risk) vs general pop were similar ⭐️'Hypothetical' treatment profile best aligned to abatacept @Rheumnow https://t.co/r4y7SZbjTA

Survival of RA-ILD pts w/ lung 🫁 transplantation Retrospective single centre study *Mortality 36% *Usual Interstitial Pneumonia worst prognosis w/ HR 7.13 (did not reach significance, small cohort) *Survival time comparable to other lung Tx cohorts #EULAR2022 OP0275 @RheumNow https://t.co/LslPxyXJCp

To contrast or not to contrast (in RA hand MRI?) POS0718 from #EULAR2022 showed good correlation between contrast/non-contrast imaging in synovitis, less so in tenosynovitis however. https://t.co/xL4XcRlIog @RheumNow https://t.co/0cTep6MHLu

• Module

Treat-to-target in RA is held with an almost religious fervour in rheumatology, but it's really hard to follow religiously. What happens if you're only T2T observant on the high holidays? Answer: the world's not too bad! (2y is bit short I realise) POS0111 #EULAR2022 @RheumNow https://t.co/Boh74JmsP3